BioMark Diagnostics Inc.
BUX
Ранг среди акций
#26640
BioMark Diagnostics Inc. is an oncology specialist, developing advanced... BioMark Diagnostics Inc. is an oncology specialist, developing advanced diagnostic tools for cancer to enable early detection, continuous patient monitoring, and the assessment of initial treatment efficacy. The firm holds a research partnership with the Icahn School of Medicine, collaborating on clinical trials specifically addressing the early identification of lung cancer. Founded in 2014, its corporate headquarters are situated in Richmond, Canada. BioMark Diagnostics Inc. operates as a subsidiary of Biomark Technologies Inc.
Цена акции
$0.33433516
Последняя синхронизация: 2026-10-20
Рыночная капитализация
$35.60M
Изменение (1 день)
-3.08%
Изменение (1 год)
39.31%
Страна
CA
Торговля BioMark Diagnostics Inc. (BUX)
Категория
Healthcare
История цены акций BioMark Diagnostics Inc. (BUX)
Наивысшая цена закрытия: $0.38 2026-10-01
Наименьшая цена закрытия: $0.35 2015-03-01
Наименьшая цена закрытия: $0.35 2015-03-01
История цены акций BioMark Diagnostics Inc. с 2015 по 2026
Годовая динамика цены акций
| Год | Результативность |
|---|---|
| 2026 (TTM) | 6.88% |
| 2025 | 136.71% |
| 2024 | -19.87% |
| 2023 | 29.58% |
| 2022 | -34.72% |
| 2021 | 122.09% |
| 2020 | -51.07% |
| 2019 | 376.19% |
| 2018 | -44.93% |
| 2017 | -9.77% |
| 2016 | -22.98% |
| 2015 | 0.00% |
Цена акций похожих компаний или конкурентов
| Компания | Цена акций | Изменение 1г% | Страна |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $21.28 | 50.29% |
CN
|
|
| $177.93 | 21.98% |
US
|
